ABVC BIOPHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Abvc Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Abvc Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 14, 2024 was 12.4M shares, a 214% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 12.4M +8.47M +214% Aug 14, 2024 10-Q 2024-08-14
Q1 2024 10.6M -22.5M -68.1% Mar 12, 2024 10-K/A 2024-03-15
Q3 2023 7.23M -25.4M -77.8% Nov 9, 2023 10-Q 2023-11-15
Q2 2023 3.95M -28.7M -87.9% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 33.1M +2.77M +9.15% Mar 31, 2023 10-K 2023-03-31
Q3 2022 32.6M +4.02M +14.1% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 32.6M +8.16M +33.4% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 30.3M +5.89M +24.1% Mar 30, 2022 10-K/A 2022-06-06
Q3 2021 28.6M +7.8M +37.5% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 24.5M +4.98M +25.6% Aug 11, 2021 10-Q 2021-08-12
Q1 2021 24.4M +4.93M +25.3% Mar 15, 2021 10-K 2021-03-16
Q3 2020 20.8M Nov 12, 2020 10-Q 2020-11-17
Q2 2020 19.5M +1.37M +7.53% Jun 26, 2020 10-Q 2020-06-30
Q1 2020 19.5M -194M -90.9% May 11, 2020 10-K 2020-05-15
Q4 2019 19.5M Nov 15, 2019 10-Q 2019-11-18
Q2 2019 18.1M Aug 7, 2019 10-Q 2019-08-09
Q1 2019 214M 0 0% Apr 8, 2019 10-K 2019-04-15
Q3 2018 214M +180K +0.08% Nov 13, 2018 10-Q 2018-11-14
Q1 2018 214M Mar 28, 2018 10-KT 2018-04-13
Q3 2017 214M Aug 18, 2017 10-Q/A 2018-03-19
Q2 2017 214M +4.39M +2.1% May 19, 2017 10-Q/A 2018-03-19
Q4 2016 211M +151M +251% Jan 6, 2017 10-K/A 2017-09-22
Q2 2016 209M +155M +283% Aug 10, 2016 10-Q/A 2017-02-22
Q1 2016 66.4M +11.8M +21.7% Feb 18, 2016 10-Q 2016-02-23
Q4 2015 60M +5.42M +9.93% Nov 25, 2015 10-K 2015-11-27
Q2 2015 54.6M Jul 31, 2015 10-Q 2015-08-19
Q1 2015 54.6M Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 54.6M Dec 31, 2014 10-Q 2015-04-17
Q4 2012 54.6M +38.3M +234% Dec 31, 2012 10-Q 2015-04-16
Q2 2012 54.5M +43.9M +412% Jun 30, 2012 10-Q/A 2012-08-20
Q4 2011 16.3M Jan 31, 2012 10-Q 2012-02-21
Q2 2011 10.7M Jul 15, 2011 10-Q/A 2011-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.